Keyword: Sandoz

News

FDA Releases Naming Rules for Biosimilars

31.08.2015 - The US Food and Drug Administration has released a proposal for naming biosimilars – lower-cost biotech drugs – almost simultaneously with the market launch of the first such...

News

US Sandoz Arm Fights US Overpay Lawsuit

18.06.2015 - Sandoz, Inc., the US arm of Novartis’ generic drugs division, is asking the Supreme Court of the US state of Mississippi to reverse a county court’s $38.2 million judgment against...

News

Mylan Said to Prepare Poison Pill Potion Against Teva

24.04.2015 - US-managed generics drugmaker Mylan, now domiciled in the Netherlands, is said to be preparing a "poison pill" defense to escape its pursuit by Israeli generics giant Teva. Teva...

News

FDA Approves the First-Ever US Biosimilar

16.03.2015 - The US Food & Drug Administration has approved the country's first biosimilar product, a move observers say will open the door for lower cost, generic-like biological drugs. The...

Strategy & Management

Market Leadership in Specialty Chemicals

29.07.2014 - Even if not quite 20 years old, Swiss-based specialty chemicals producer Clariant can nevertheless look back on an eventful history. With years of extensive restructuring...

News

Teva Asks U.S. Supreme Court to Stay Copaxone Ruling

08.04.2014 - Teva Pharmaceutical Industries, U.S. subsidiary of the Israeli generics drugmaker, has asked the U.S. Supreme Court to stop a lower court ruling from going into effect while the...

News

U.S. Justices Agree to Hear Teva's Copaxone Appeal

01.04.2014 - The U.S. Supreme Court on Mar. 31 agreed to hear an appeal filed by Teva Pharmaceutical Industries in a patent fight over top-selling multiple sclerosis drug Copaxone. The move...

News

The Biosimilar Market

07.02.2014 - Pharmaceuticals - Many biologic drug developers can be pleased with how well their products have performed in the market place. Blockbuster products such as Abbvie's (ex-Abbott)...